Free Trial

Circle Wealth Management LLC Reduces Holdings in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Circle Wealth Management LLC decreased its holdings in UnitedHealth Group by 18.3%, resulting in ownership of 4,182 shares valued at approximately $2.19 million.
  • CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group for around $179,645, reducing his ownership by 5.36%.
  • Several analysts have adjusted their price targets for UnitedHealth Group, with Bank of America raising it from $290 to $325, while HSBC lowered theirs from $490 to $270.
  • Looking to export and analyze UnitedHealth Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Circle Wealth Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,182 shares of the healthcare conglomerate's stock after selling 936 shares during the quarter. Circle Wealth Management LLC's holdings in UnitedHealth Group were worth $2,190,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of UNH. Citizens National Bank Trust Department lifted its position in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH grew its position in UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after buying an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $39,413,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Finally, Royal Bank Of Canada lowered their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $365.38.

Get Our Latest Report on UnitedHealth Group

UnitedHealth Group Price Performance

NYSE:UNH opened at $303.4150 on Friday. The company's 50-day moving average is $288.51 and its two-hundred day moving average is $391.21. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $274.79 billion, a price-to-earnings ratio of 13.15, a price-to-earnings-growth ratio of 1.93 and a beta of 0.43. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the firm posted $6.80 earnings per share. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines